Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

33 results about "Flaccidity" patented technology

Lack of normal muscle tone.

Traditional Chinese medicine pills for curing acute and chronic waist-leg pain and lumbar intervertebral disc bulge bone fracture dislocation

The invention relates to a traditional Chinese medicine pill for treating acute and chronic lumbago-leg pain, and lumbar intervertebral disc bulge and herniation as well as fracture dislocation, and can effectively solve the treatment problems of lumbago, leg pain, intervertebral disc herniation and bulge, flaccidity of muscles and bones, numbness of limbs, steaming bone disorder and hectic fever, traumatic injury, the fracture dislocation, inability to touch the ground by feet, and incapability of walking. The traditional Chinese medicine pill is made from the medicines as follows: cortex phellodendron is 25 to 35g, tortoise plastron is 8 to 12g, old arable soil is 16 to 20g, radix cyathulae is 18 to 22g, rhizoma anemarrhenae is 25 to 35g, Cynomorium songaricum is 12 to 17g, white peony roots are 18 to 22g, safflower is 8 to 12g, tiger-bones are 40 to 60g, red ginseng is 8 to 12g, Dipsacus japonicus Miq. is 18 to 22g, pulp of cornus is 8 to 12g, and moutan cortex is 36 to 45g; the thirteen medicines are crushed into fine powders together and mixed uniformly. The traditional Chinese medicine pills can improve the symptoms and signs of human bodies, eliminate osteal tumefaction and ache, strengthen the function and recover the functions of lumbar and limbs; the successful research of the traditional Chinese medicine pill is an innovation in traditional Chinese medicine, and the economic and social benefits are good.
Owner:康正海

Drug for treating neural injury caused by chemotherapy and preparation method of drug

InactiveCN104383495AObvious effect of promoting blood circulation and dredging collateralsImprove the quality of lifeHeavy metal active ingredientsNervous disorderSalvia miltiorrhizaCentipede
The invention discloses a drug for treating neural injury caused by chemotherapy. The drug comprises astragalus, angelica sinensis, asarum, sun-dried ginseng, lycopodium clavatum, radix clematidis, radix paeoniae alba, fresh ginger, safflowers, scorpions, earthworms, ginseng, ligusticum wallichii, salvia miltiorrhiza, peach blossoms, fructus trichosanthis, rheum officinale, epimedium herbs, ginkgo leaves, velvet antlers, radix puerariae, stiff silkworms, rhodiola rosea, leeches, tinospora sinensis, mulberry twigs, centipedes, cassia twigs, peach kernels, caulis spatholobi, liquorice, myrobalan, radix aconite kusnezoffii, rhizoma acori graminei, radix aucklandiae, musk, coral, pearls, clove, semen myristicae, agilawood, limonite and magnetite. The effects of regulating qi and blood of the whole body and dredging collaterals to remove the obstruction of qi and blood circulation are achieved according to the principles of dredging in replenishing, replenishing in dredging, replenishing and dredging combination as well as static and dynamic combination, so that the symptoms including coldness, numbness, pain and flaccidity are gradually relieved until disappearing. The drug is capable of promoting blood circulation and ensuring proper downward flow of the blood, has a remarkable effect of promoting blood circulation to remove meridian obstruction for a patient suffering from neural injury caused by chemotherapy and can also take the effects of replenishing qi and enriching the blood as well as strengthening muscles and relieving pain, so that the survival quality of the patient is improved, and the life of the patient is prolonged.
Owner:唐国永

Cosmetic laser treatment device and method for localized lipodystrophies and flaccidity

A method and device for cosmetic surgery, especially fat reduction and collagen reformation, by means of a high power laser operating at about 980 nm is presented. The cosmetic surgery method substantially reduces or removes localized lipodystrophies, and essentially reduces flaccidity by localized laser heating of adipose tissue using an optical fiber inserted into a treatment area. The method and device are particularly well suited for treating Lipodystrophies with flaccidity High power laser energy is applied to “fat” cells to breakdown the cell walls releasing the cell fluid. The laser radiation is applied through an optical fiber which may be held within a catheter-like device having a single lumen. The optical fiber may have a diffuser mounted on the tip to further apply heating to tissues surrounding the whole tip. A saline solution may also be inserted into the treatment site to aid in the heating of the fat cells and their eventual destruction as well as their removal. The pool of cell fluid in the area of treatment is removed by a combination of techniques including allowing the body to remove it by absorption and drainage from the entry sites thus minimizing trauma to the area of treatment and hastening recovery. Additional techniques to remove the cell fluid include direct force application by means of elastic bandages and external suction applied to the entry sites. Quick and lasting cosmetic changes, even in areas having prior untreatable fat tissues, are achieved while minimizing trauma to the treatment areas.
Owner:BIOLITEC UNTERNEHMENSBETEILLIGUNGS II AG

Traditional Chinese medicine composition containing poria cocos for treating dermatomyositis and preparation thereof

The invention provides a Chinese medicine composite containing poria for curing dermatomyositis and a preparation thereof. In the collateral disease theory of traditional Chinese medicine, dermatomyositis is ascribed to 'flaccidity syndrome', the pathogenesis mainly includes deficiency of spleen and kidney, no source of the production and transformation of qi and blood, the incapability of weakened body resistance to inhibit pathogen, and the stagnation of skin channels by chill and dampness and heat, thus further affecting liver, kidney and spleen, causing the stasis of viscera yin collaterals, qi-blood disharmony, as well as malnutrition of the tendons and channels of limb skin. The composite adopts the collateral disease theory of traditional Chinese medicine and aims at such pathogenesis of dermatomyositis as dampness-heat retention in spleen and stagnation of qi and collateral stagnation to determine the treatment based on differentiation of symptoms and signs; the materials of poria, the rhizome of large-headed atractylodes, phellodendron, achyranthes, coixseed, rhizoma coptidis, fructus tsaoko, magnolia officinalis, herba artemisiae capillaris, eupatorium japonicum, balloon flower and safflower are selected and used, thus obtaining the efficacies of invigorating the spleen for removing the dampness, clearing away heat and toxic material, regulating qi and dredging channels. Tested by clinical study, the composite can effectively cure the dermatomyositis.
Owner:HEBEI YILING MEDICINE INST

Traditional Chinese medicine composition containing epimeddium for treating dermatomyositis and preparation thereof

The invention provides a traditional Chinese medicine composition containing epimedium powder for treating dermatomyositis and a preparation thereof. The dermatomyositis is classified as 'flaccidity syndrome' by the theory of collateral diseases of the Chinese traditional medicine, and the pathogenesis of the dermatomyositis is mainly the deficiency of the spleen and the kidney, no source for the production and transformation of qi and blood, inability of the weakened body resistance to conquer pathogen, and obstruction of the collaterals of muscles and skin by wind cold dampness, thus affecting the liver, the kidney and the spleen and causing the yin collaterals stasis of internal organs, qi-blood disharmony, and malnutrition of the limbs, skin, tendons and channels. Aiming at treating syndromes of yang deficiency of the liver and the kidney, and obstruction of collaterals by cold dampness due to the dermatomyositis, the traditional Chinese medicine composition determines the treatment based on differentiation of symptoms and signs by using the theory of the collateral diseases of Chinese traditional medicine, and is made from rhizoma curculiginis, the epimedium powder, cassia twig, astragalus root, white atractylodes rhizome, poria, Chinese ephedra, radix aconiti, scorpion, angelica, notopterygium root and heracleum hemsleyanum michaux to warm yang and nourish kidney, invigorate spleen and eliminate dampness and expel cold and activate the channels. Clinical studies prove that the traditional Chinese medicine composition can treat the dermatomyositis effectively.
Owner:HEBEI YILING MEDICINE INST

Traditional Chinese medicinal composition for treating flaccidity disease

The invention discloses a traditional Chinese medicinal composition for treating flaccidity disease. The composition comprises the following raw materials by weight: 10-30 parts of fructus corni, 10-20 parts of bighead atractylodes rhizome, 10-20 parts of Polygonum multiflorum, 5-15 parts of dried orange peel, 10-20 parts of gypsum, 10-20 parts of Mangnolia officinalis, 10-20 parts of Eucommia, 5-15 parts of large-leaved gentian, 10-20 parts of mother of pearl, 10-20 parts of Rhizoma Gastrodia, 5-15 parts of rhizoma anemarrhenae, 10-20 parts of herba siegesbeckiae, 10-20 parts of Dioscorea pentaphylla, 10-15 parts of magnetite, 5-10 parts of Cimicifuga, 10-20 parts of semen dolichoris, 10-20 parts of scarlet kadsura root, 5-15 parts of radix angelicae tuhuo, 10-20 parts of rhizoma cibotii, 10-20 parts of herba cistanches, 10-20 parts of lycopodium clavatum, 5-15 parts of radix aconiti carmichaeli, 10-20 parts of Fritillaria thunbergii Miq., and 5-15 parts of licorice. The traditional Chinese medicinal composition of the invention has the effects of invigorating spleen, tonifying kidney, clearing heat and draining dampness, benefiting qi, invigorating the circulation of blood, dispelling wind and relaxing vein, has significant curative effect in the treatment of flaccidity disease, and is safe and reliable.
Owner:冷国玉

Traditional Chinese medicine composition containing cicada-shell for treating dermatomyositis and preparation method thereof

The invention provides a traditional Chinese medicine composition containing cicada shell for treating dermatomyositis and a preparation thereof. The dermatomyositis is classified as 'flaccidity syndrome' by the theory of collateral diseases of the Chinese traditional medicine, and the pathogenesis of the dermatomyositis is mainly the deficiency of the spleen and the kidney, no source for the production and transformation of qi and blood, inability of the weakened body resistance to conquer pathogen, and obstruction of the collaterals of muscles and skin by wind cold dampness, thus affecting the liver, the kidney and the spleen and causing the yin collaterals stasis of internal organs, qi-blood disharmony, and malnutrition of the limbs, skin, tendons and channels. Aiming at treating syndromes of obstruction of channels and collaterals and collateral deficiency caused by pathogen of the dermatomyositis, the traditional Chinese medicine composition determines the treatment based on differentiation of symptoms and signs by the theory of the collateral deficiency of Chinese traditional medicine, and is made from dried rehmannia root, turtle shell, white mustard seed, angelica root, astragalus root, scorpion, spatholobus stem and cicada shell to regulate the nutrient and tonify deficiency, and eliminate the pathogenic factors and activate the channels. Clinical studies prove that the traditional Chinese medicine composition can treat the dermatomyositis effectively.
Owner:HEBEI YILING MEDICINE INST

Traditional Chinese medicine composition containing chinemys reevesii for treating dermatomyositis and preparation thereof

The invention provides a traditional Chinese medicine composition which contains tortoise plastron and is used for treating dermatomyositis and a preparation thereof. The dermatomyositis is classified as 'flaccidity syndrome' by the theory of collateral diseases of the Chinese traditional medicine, and the pathogenesis of the dermatomyositis is mainly the deficiency of the spleen and the kidney, no source for the production and transformation of qi and blood, inability of the weakened body resistance to conquer pathogen, and obstruction of the collaterals of muscles and skin by wind cold dsmpness, thus affecting the liver, the kidney and the spleen and causing the yin collaterals stasis of internal organs, qi-blood disharmony, and malnutrition of the limbs, skin, tendons and channels. Aiming at treating syndromes of yin deficiency of the liver and the kidney, and weakness and stasis of collaterals and channels caused by the dermatomyositis, the Chinese traditional medicine composition determines the treatment based on differentiation of symptoms and signs by the theory of the collateral deficiency of Chinese traditional medicine, and is made from dried rehmannia root, the tortoise plastron, turtle shell, eclipta, glossy privet fruit, sweet wormwood, dogwood fruit, mistletoe, Chinese wolfberry, moutan bark, earth worm and batryticated silkworm to invigorate the liver and kidney and replenish vital essence for removing obstruction from the channels. Clinical studies prove that the traditional Chinese medicine composition can treat the dermatomyositis effectively.
Owner:HEBEI YILING MEDICINE INST

Traditional Chinese medicine composition containing chinemys reevesii for treating dermatomyositis and preparation thereof

The invention provides a traditional Chinese medicine composition which contains tortoise plastron and is used for treating dermatomyositis and a preparation thereof. The dermatomyositis is classified as 'flaccidity syndrome' by the theory of collateral diseases of the Chinese traditional medicine, and the pathogenesis of the dermatomyositis is mainly the deficiency of the spleen and the kidney, no source for the production and transformation of qi and blood, inability of the weakened body resistance to conquer pathogen, and obstruction of the collaterals of muscles and skin by wind cold dsmpness, thus affecting the liver, the kidney and the spleen and causing the yin collaterals stasis of internal organs, qi-blood disharmony, and malnutrition of the limbs, skin, tendons and channels. Aiming at treating syndromes of yin deficiency of the liver and the kidney, and weakness and stasis of collaterals and channels caused by the dermatomyositis, the Chinese traditional medicine compositiondetermines the treatment based on differentiation of symptoms and signs by the theory of the collateral deficiency of Chinese traditional medicine, and is made from dried rehmannia root, the tortoiseplastron, turtle shell, eclipta, glossy privet fruit, sweet wormwood, dogwood fruit, mistletoe, Chinese wolfberry, moutan bark, earth worm and batryticated silkworm to invigorate the liver and kidneyand replenish vital essence for removing obstruction from the channels. Clinical studies prove that the traditional Chinese medicine composition can treat the dermatomyositis effectively.
Owner:HEBEI YILING MEDICINE INST

Traditional Chinese medicine for treating liver-kidney deficiency type flaccidity diseases

The invention discloses a traditional Chinese medicine for treating liver-kidney deficiency type flaccidity diseases. The traditional Chinese medicine is prepared from the following medicines in partsby weight: 9-15 parts by weight of semen cuscutae, 6-12 parts by weight of loranthus parasiticus, 6-9 parts by weight of herba cistanches, 6-12 parts by weight of radix rehmanniae preparata, 3-9 parts by weight of radix glycyrrhizae. According to the theory of traditional Chinese medicine, the theory of syndrome differentiation and treatment is adopted by the invention to screen Chinese herbal formulas; the traditional Chinese medicine is scientific and reasonable in formula, simple in configuration, free of toxic or side effects, short in curative effect and quick in effect. Based on the principles of nourishing liver and kidney, replenishing essence and filling marrow, and for patients with liver and kidney deficiency type flaccidity diseases and pathogenesis of liver-kidney deficiency,marrow withering and tendon flaccidity, the traditional Chinese medicine is capable of mainly nourishing the liver and kidney, supplemented by replenishing the essence and filling the marrow; and thewhole formula has the effects of nourishing liver and kidney, replenishing essence and filling marrow.
Owner:丁武沛

Cosmetic laser treatment device and method for localized lipodystrophies and flaccidity

A method and device (100) for cosmetic surgery, especially fat reduction and collagen reformation, by means of a high power laser operating at about 980 nm is presented. The cosmetic surgery method substantially reduces or removes localized lipodystrophies, and essentially reduces flaccidity by localized laser heating of adipose tissue using an optical fiber (102) inserted into a treatment area. The method and device (100) are particularly well suited for treating Lipodystrophies with flaccidity High power laser energy is applied to ''fat'' cells to breakdown the cell walls releasing the cellfluid. The laser radiation is applied through an optical fiber (100), which may be held within a catheter-like device having a single lumen. The optical fiber may have a diffuser mounted on the tip tofurther apply heating to tissues surrounding the whole tip. A saline solution may also be inserted into the treatment site to aid in the heating of the fat cells and their eventual destruction as well as their removal. The pool of cell fluid in the area of treatment is removed by a combination of techniques including allowing the body to remove it by absorption and drainage from the entry sites thus minimizing trauma to the area of treatment and hastening recovery. Additional techniques to remove the cell fluid include direct force application by means of elastic bandages and external suctionapplied to the entry sites. Quick and lasting cosmetic changes, even in areas having prior untreatable fat tissues, are achieved while minimizing trauma to the treatment areas.
Owner:BIOLITEC UNTERNEHMENSBETEILLIGUNGS II AG

Female physiological cycle regulation powder

The invention discloses female physiological cycle regulation powder, which is prepared from the following ingredients: 40 to 50g of small yellow ginger, 1 to 5g of dendrobe, 1 to 5g of serissa japonica, 6 to 10g of radix sileris, 3 to 7g of glossy privet fruit, 3 to 7g of herba cynomorii, 3 to 9g of Dragon's bone, 3 to 9g of cortex phellodendri, 3 to 9g of cortex albiziae and 3 to 7g of schisandra chinensis. A preparation process of the female physiological cycle regulation powder comprises the following steps of S1, selection; S2, frying; S3, primary grinding; S4, drying in the sun; S5, secondary grinding; S6, mixing; S7, packaging. The female physiological cycle regulation powder is generally used for symptoms of insufficiency of kidney-yang, blood and essence asthenia, waist knee flaccidity, impotence spermatorrhea, intestine dryness and constipation. The fruit of Chinese magnoliavine has the effects of realizing convergence, inducing astringency, nourishing qi to generate fluid, tonifying kidney and calming the heart; the female physiological cycle regulation powder has the functions of dissipating blood stasis to remove moistness, removing blood stasis to eliminate toxicity and strengthening the spleen and stomach; the female physiological cycle regulation powder is suitable for being used by people groups with irregular menstruation, menorrhagia, hypomenorrhea, epimenorrhea, menstruation delay, endometrium denudation disorder, dysmenorrhea, lower abdominal pain and distension, and lower abdominal cold and distension.
Owner:彭婉蓉
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products